Veterinary CRO And CDMO Market is estimated to increase at a growth rate of 8.9% CAGR over the forecast period from 2024 to 2030.
The global Veterinary CRO And CDMO Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Animal Type (Companion Animals, Livestock Animals), By ServiceType, Discovery, Development, Manufacturing, Packaging & Labeling, Market Approval & Post-Marketing), By Application (Pharmaceuticals, Biologics, Medical Devices).
An introduction to Veterinary CRO And CDMO Market in 2024
The Veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) Market cater to the outsourcing needs of the veterinary pharmaceutical and biotechnology industries, offering a range of research, development, and manufacturing services for veterinary drugs and biological products. Veterinary CROs provide preclinical research, clinical trials, regulatory support, and consulting services, while veterinary CDMOs offer formulation development, manufacturing process optimization, and contract manufacturing services for veterinary pharmaceuticals, biologics, and vaccines. With the increasing complexity of veterinary drug development and the need for specialized expertise and infrastructure, the veterinary CRO and CDMO market plays a crucial role in supporting innovation, accelerating product development timelines, and ensuring regulatory compliance in the veterinary healthcare sector.
Veterinary CRO And CDMO Market Trend: Increasing Outsourcing of Veterinary Drug Development Activities
One prominent trend in the Veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market is the increasing outsourcing of veterinary drug development activities by pharmaceutical companies and animal health organizations. As the demand for novel veterinary therapeutics continues to grow, companies are seeking to streamline their drug development processes, reduce costs, and accelerate time-to-market for new products. Outsourcing to veterinary CROs and CDMOs offers several advantages, including access to specialized expertise, state-of-the-art facilities, and flexible service offerings tailored to the unique needs of the veterinary market. Additionally, outsourcing allows companies to focus on core competencies, mitigate risks, and leverage external resources for preclinical research, formulation development, clinical trials, and manufacturing of veterinary pharmaceuticals. This trend towards outsourcing reflects the evolving dynamics of the veterinary pharmaceutical industry and drives market growth in the Veterinary CRO and CDMO market.
Veterinary CRO And CDMO Market Driver: Increasing Investment in Companion Animal Healthcare and Therapeutics
A significant driver in the Veterinary CRO and CDMO market is the increasing investment in companion animal healthcare and therapeutics by pet owners, veterinarians, and pharmaceutical companies. Companion animals, including dogs, cats, and horses, play an integral role in households as beloved companions and family members, driving the demand for high-quality veterinary healthcare services and pharmaceutical products. Pet owners are increasingly willing to invest in preventive care, diagnostics, and treatment options to ensure the health and well-being of their animal companions, leading to a growing market for veterinary therapeutics targeting companion animal diseases and conditions. Pharmaceutical companies are responding to this demand by investing in the development of innovative veterinary drugs, vaccines, and biologics for companion animals, thereby driving the need for outsourced research, development, and manufacturing services from veterinary CROs and CDMOs. The increasing investment in companion animal healthcare serves as a key driver for market growth and expansion in the Veterinary CRO and CDMO market.
Veterinary CRO And CDMO Market Opportunity: Expansion into Regulatory Support Services and Global Market Access
An emerging opportunity in the Veterinary CRO and CDMO market lies in the expansion into regulatory support services and global market access solutions for veterinary pharmaceutical products. Regulatory requirements for veterinary drug development and marketing authorization vary across regions and countries, posing challenges for companies seeking to navigate complex regulatory landscapes and obtain timely approvals for their products. Veterinary CROs and CDMOs have the opportunity to provide comprehensive regulatory consulting services, dossier preparation, and submission support to clients, facilitating compliance with regulatory requirements and expediting market access for veterinary pharmaceuticals worldwide. Additionally, there is potential to offer specialized expertise in veterinary regulatory affairs, pharmacovigilance, and post-marketing surveillance to ensure ongoing regulatory compliance and product safety throughout the product lifecycle. By expanding into regulatory support services and global market access solutions, stakeholders can enhance their service offerings, address customer needs, and capitalize on opportunities for market growth and differentiation in the Veterinary CRO and CDMO market.
Veterinary CRO And CDMO Market Market Segmentation
By Animal Type
Companion Animals
Livestock Animals
By ServiceType
Discovery
Development
-Early phase/preclinical
-Late phase/clinical
Manufacturing
Packaging & Labeling
Market Approval & Post-Marketing
By Application
Medicines
-Pharmaceuticals
-Biologics
-Others
Medical Devices
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Veterinary CRO And CDMO Market Companies
Charles River Laboratories
Clinvet
IDEXX Laboratories
Inotiv
KLIFOVET GmbH
Knoell – Triveritas
Labcorp Drug Development
Oncovet Clinical Research
Veterinary Research Management
Vetio
VETSPIN
Zoetis
Reasons to Buy the Veterinary CRO And CDMO Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Veterinary CRO And CDMO Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Veterinary CRO And CDMO Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Veterinary CRO And CDMO Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Veterinary CRO And CDMO Market Size Outlook, $ Million, 2021 to 2030
3.2 Veterinary CRO And CDMO Market Outlook by Type, $ Million, 2021 to 2030
3.3 Veterinary CRO And CDMO Market Outlook by Product, $ Million, 2021 to 2030
3.4 Veterinary CRO And CDMO Market Outlook by Application, $ Million, 2021 to 2030
3.5 Veterinary CRO And CDMO Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Veterinary CRO And CDMO Industry
4.2 Key Market Trends in Veterinary CRO And CDMO Industry
4.3 Potential Opportunities in Veterinary CRO And CDMO Industry
4.4 Key Challenges in Veterinary CRO And CDMO Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Veterinary CRO And CDMO Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Veterinary CRO And CDMO Market Outlook by Segments
7.1 Veterinary CRO And CDMO Market Outlook by Segments, $ Million, 2021- 2030
By Animal Type
Companion Animals
Livestock Animals
By ServiceType
Discovery
Development
-Early phase/preclinical
-Late phase/clinical
Manufacturing
Packaging & Labeling
Market Approval & Post-Marketing
By Application
Medicines
-Pharmaceuticals
-Biologics
-Others
Medical Devices
8 North America Veterinary CRO And CDMO Market Analysis and Outlook To 2030
8.1 Introduction to North America Veterinary CRO And CDMO Markets in 2024
8.2 North America Veterinary CRO And CDMO Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Veterinary CRO And CDMO Market size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
Livestock Animals
By ServiceType
Discovery
Development
-Early phase/preclinical
-Late phase/clinical
Manufacturing
Packaging & Labeling
Market Approval & Post-Marketing
By Application
Medicines
-Pharmaceuticals
-Biologics
-Others
Medical Devices
9 Europe Veterinary CRO And CDMO Market Analysis and Outlook To 2030
9.1 Introduction to Europe Veterinary CRO And CDMO Markets in 2024
9.2 Europe Veterinary CRO And CDMO Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Veterinary CRO And CDMO Market Size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
Livestock Animals
By ServiceType
Discovery
Development
-Early phase/preclinical
-Late phase/clinical
Manufacturing
Packaging & Labeling
Market Approval & Post-Marketing
By Application
Medicines
-Pharmaceuticals
-Biologics
-Others
Medical Devices
10 Asia Pacific Veterinary CRO And CDMO Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Veterinary CRO And CDMO Markets in 2024
10.2 Asia Pacific Veterinary CRO And CDMO Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Veterinary CRO And CDMO Market size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
Livestock Animals
By ServiceType
Discovery
Development
-Early phase/preclinical
-Late phase/clinical
Manufacturing
Packaging & Labeling
Market Approval & Post-Marketing
By Application
Medicines
-Pharmaceuticals
-Biologics
-Others
Medical Devices
11 South America Veterinary CRO And CDMO Market Analysis and Outlook To 2030
11.1 Introduction to South America Veterinary CRO And CDMO Markets in 2024
11.2 South America Veterinary CRO And CDMO Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Veterinary CRO And CDMO Market size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
Livestock Animals
By ServiceType
Discovery
Development
-Early phase/preclinical
-Late phase/clinical
Manufacturing
Packaging & Labeling
Market Approval & Post-Marketing
By Application
Medicines
-Pharmaceuticals
-Biologics
-Others
Medical Devices
12 Middle East and Africa Veterinary CRO And CDMO Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Veterinary CRO And CDMO Markets in 2024
12.2 Middle East and Africa Veterinary CRO And CDMO Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Veterinary CRO And CDMO Market size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
Livestock Animals
By ServiceType
Discovery
Development
-Early phase/preclinical
-Late phase/clinical
Manufacturing
Packaging & Labeling
Market Approval & Post-Marketing
By Application
Medicines
-Pharmaceuticals
-Biologics
-Others
Medical Devices
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Charles River Laboratories
Clinvet
IDEXX Laboratories
Inotiv
KLIFOVET GmbH
Knoell – Triveritas
Labcorp Drug Development
Oncovet Clinical Research
Veterinary Research Management
Vetio
VETSPIN
Zoetis
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Animal Type
Companion Animals
Livestock Animals
By ServiceType
Discovery
Development
-Early phase/preclinical
-Late phase/clinical
Manufacturing
Packaging & Labeling
Market Approval & Post-Marketing
By Application
Medicines
-Pharmaceuticals
-Biologics
-Others
Medical Devices
